Fertility Focus is delighted to have been voted one of the Top 40 Digital Health and Medtech Companies in Europe 2017.
This year’s 40 companies were chosen from over 250 nominations and 130 applications. They come from 14 different countries and are engaged in sectors including genomics and sequencing, wearables, telemedicine, digital medical devices, population health, big data and analytics, cardiology, orthopaedics, neurology, ophthalmology, and robotics. Fertility Focus CEO, Rob Milnes, says “This award is a great recognition of the growth in our OvuSense realtime fertility monitor business. OvuSense is helping more and more women to achieve their dreams of pregnancy. It puts the user in control by predicting ovulation in real time using in-cycle data”